MITHRIDATE, A Multicenter International sTudy comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

Project: Research

Participants

Short titleMITHRIDATE, A Multicenter International sTudy comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera
StatusActive
Effective start/end date21/09/1820/09/29